Maxcyte annual gross profit
2019
2020
2021
2022
2023
2024
2025
Maxcyte Gross Profit Growth & History (MXCT)
Maxcyte's gross profit was $26.8M for fiscal 2025.
View full Maxcyte company overviewMaxcyte annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $26.8M | −$4.7M | −14.98% |
| 2024 | 2024-12-31 | $31.5M | −$5.0M | −13.73% |
| 2023 | 2023-12-31 | $36.5M | −$2.6M | −6.68% |
| 2022 | 2022-12-31 | $39.2M | $8.9M | +29.48% |
| 2021 | 2021-12-31 | $30.2M | $6.8M | +29.25% |
| 2020 | 2020-12-31 | $23.4M | $4.3M | +22.39% |
| 2019 | 2019-12-31 | $19.1M | — | — |
Maxcyte quarterly gross profit
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.6M | −$1.4M | −19.92% |
| Q1 2026 | 2026-03-31 | $8.1M | −$811,000 | −9.12% |
| Q4 2025 | 2025-12-31 | $5.7M | −$721,000 | −11.25% |
| Q3 2025 | 2025-09-30 | $5.2M | −$1.0M | −16.08% |
| Q2 2025 | 2025-06-30 | $7.0M | −$2.0M | −21.84% |
| Q1 2025 | 2025-03-31 | $8.9M | −$1.0M | −10.52% |
| Q4 2024 | 2024-12-31 | $6.4M | −$7.7M | −54.51% |
| Q3 2024 | 2024-09-30 | $6.2M | −$975,000 | −13.52% |
| Q2 2024 | 2024-06-30 | $8.9M | $1.3M | +16.62% |
| Q1 2024 | 2024-03-31 | $9.9M | $2.4M | +31.19% |
| Q4 2023 | 2023-12-31 | $14.1M | $3.2M | +29.56% |
| Q3 2023 | 2023-09-30 | $7.2M | −$2.1M | −22.24% |
| Q2 2023 | 2023-06-30 | $7.7M | −$820,400 | −9.67% |
| Q1 2023 | 2023-03-31 | $7.6M | −$2.9M | −28.02% |
| Q4 2022 | 2022-12-31 | $10.9M | $2.0M | +21.86% |
| Q3 2022 | 2022-09-30 | $9.3M | $78,600 | +0.85% |
| Q2 2022 | 2022-06-30 | $8.5M | $2.2M | +34.22% |
| Q1 2022 | 2022-03-31 | $10.5M | $4.7M | +81.40% |
| Q4 2021 | 2021-12-31 | $8.9M | — | — |
| Q3 2021 | 2021-09-30 | $9.2M | $3.2M | +52.55% |
| Q2 2021 | 2021-06-30 | $6.3M | $1.6M | +35.00% |
| Q1 2021 | 2021-03-31 | $5.8M | — | — |
| Q3 2020 | 2020-09-30 | $6.0M | — | — |
| Q2 2020 | 2020-06-30 | $4.7M | — | — |
Maxcyte gross profit trends
Over the last five fiscal years, Maxcyte's gross profit increased from $23.4M to $26.8M, a change of $3.4M. The latest reported quarter, Q2 2026, shows $5.6M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maxcyte source filings ↗